Vitamin D Supplementation in Acne

HITEC-Institute of Medical Sciences

Status: Enrolling

Conditions: Acne Vulgaris

Treatments: Drug: Adapalene; Drug: Azithromycin 250 milligram Oral Capsule; Dietary Supplement: D Max Drops

Study type: Interventional

Funder types: Other

Identifiers

NCT06141330

Vit-D

Details and patient eligibility

About

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:

• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.

Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.

Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.

Enrollment: 58 estimated patients

Sex: All

Ages: 13 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.

Exclusion criteria

• Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
• Those with obesity
• Individuals employing vitamin supplementation
• Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

58 participants in 2 patient groups

Vitamin D

Experimental group

Treatment:

Dietary Supplement: D Max Drops

Drug: Azithromycin 250 milligram Oral Capsule

Drug: Adapalene

Placebo

Active Comparator group

Treatment:

Drug: Azithromycin 250 milligram Oral Capsule

Drug: Adapalene